Explore more publications!

The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on December 10, 2025

IRVINEi to Debut OVAL - the World’s First AI Home Hub - at CES 2026
Beverly Hills Cosmetic Dentist Crafts JoJo Siwa’s $50K Smile Makeover
Artificio Launches Specialized AI Solutions for Insurance Claims, Legal Discovery, and Medical Records Processing
Uber Joins ConnectSafely to Help Families and Seniors Stay Safe on the Road
Hills Construction, Inc. Selects SocialSellinator to Accelerate Business Development with Strategic Google Ads Campaign
BAREIS MLS Joins RealReports’ Explosive 2025 Expansion
Rootstock Software Launches New Managed Services Offering
AqueoUS Vets® Partners with R2O Technologies to Continue Northeast Support
TechMatter Goes AI-First by Choosing Rinova AI and Raising the Bar for Medical Billing
Marketstrat Releases ‘World Market for Oncology Imaging AI 2023–2032,’ Mapping a US$604.7M Market to US$7.74B by 2032
Selecting and Filtering in 3D CAD Assemblies: Faster Overview and Less Effort in the new Kisters 3DViewStation
MindPal.co Launches AI Recruiter Agent to Revolutionize Blue-Collar Hiring, Slashing Time-to-Hire and Operational Costs
150 Children to Receive Christmas Gifts and Meals This Week Funded Entirely by Cryptocurrency Donations
How Swell Country Scaled an Ecommerce Brand from $200K to $10M
DailyLifeBuddy Launches Privacy-First AI Life OS for Integrative Health, Emotional Wellness, and Personal Success
24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business
BLOX Markets Integrates Aeron® by Adaptive to Power its Upcoming Retail-Focused U.S. Equities Trading Venue
Acquia Releases Next Generation SaaS CMS with Built-In AI Agents
Lightrun ‘Runtime Context’ Empowers AI Coding Agents to Build Software That Works in the Real World
Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions